Clinical Trials Directory

Trials / Completed

CompletedNCT02183714

The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
146 (actual)
Sponsor
Boehringer Ingelheim · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To evaluate the effect of Songha Night ® on insomnia, anxiety and quality of life compared to placebo in patients with mild to moderate insomnia.

Conditions

Interventions

TypeNameDescription
DRUGSongha Night ®
DRUGPlacebo

Timeline

Start date
1998-05-01
Primary completion
1998-12-01
First posted
2014-07-08
Last updated
2014-07-08

Source: ClinicalTrials.gov record NCT02183714. Inclusion in this directory is not an endorsement.

The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances (NCT02183714) · Clinical Trials Directory